These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 11889454

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment.
    Davis TA, Grillo-López AJ, White CA, McLaughlin P, Czuczman MS, Link BK, Maloney DG, Weaver RL, Rosenberg J, Levy R.
    J Clin Oncol; 2000 Sep; 18(17):3135-43. PubMed ID: 10963642
    [Abstract] [Full Text] [Related]

  • 6. Intratumoral but not systemic delivery of CpG oligodeoxynucleotide augments the efficacy of anti-CD20 monoclonal antibody therapy against B cell lymphoma.
    Betting DJ, Yamada RE, Kafi K, Said J, van Rooijen N, Timmerman JM.
    J Immunother; 2009 Sep; 32(6):622-31. PubMed ID: 19483647
    [Abstract] [Full Text] [Related]

  • 7. Treatment of B-cell non-Hodgkin's lymphoma with anti CD 20 monoclonal antibody Rituximab.
    Sacchi S, Federico M, Dastoli G, Fiorani C, Vinci G, Clò V, Casolari B.
    Crit Rev Oncol Hematol; 2001 Jan; 37(1):13-25. PubMed ID: 11164715
    [Abstract] [Full Text] [Related]

  • 8. Radiolabeled anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoma.
    Dillman RO.
    J Clin Oncol; 2002 Aug 15; 20(16):3545-57. PubMed ID: 12177115
    [No Abstract] [Full Text] [Related]

  • 9. New monoclonal antibody approved as lymphoma therapy.
    Am J Health Syst Pharm; 1998 Jan 15; 55(2):110. PubMed ID: 9465971
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
    Iguchi T, Miyazawa K, Okabe S, Kawakubo K, Shimamoto T, Kuriyama Y, Ito Y, Kimura Y, Ohyashiki K, Serizawa H, Iwaya K, Mukai K.
    Rinsho Ketsueki; 2004 Oct 15; 45(10):1129-34. PubMed ID: 15553050
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunotherapy for low-grade non-hodgkin secondary lymphoma of the orbit.
    Esmaeli B, Murray JL, Ahmadi MA, Naderi A, Singh S, Romaguera J, White CA, McLaughlin P.
    Arch Ophthalmol; 2002 Sep 15; 120(9):1225-7. PubMed ID: 12215104
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Rituximab and hematological malignancy].
    Hatake K, Mishima Y, Terui Y.
    Nihon Rinsho; 2004 Jul 15; 62(7):1321-4. PubMed ID: 15283150
    [Abstract] [Full Text] [Related]

  • 16. Anti-CD20 monoclonal antibody (Rituximab) for therapy of mediastinal CD20-positive large B-cell non-Hodgkin lymphoma with a local tumor extension into the lung of a 10-year-old girl.
    Culić S, Culić V, Armanda V, Kuljis D, Pesutić-Pisac V, Janković S.
    Pediatr Hematol Oncol; 2003 Jun 15; 20(4):339-44. PubMed ID: 12746167
    [Abstract] [Full Text] [Related]

  • 17. Treatment of primary cutaneous follicular centre lymphoma with rituximab: a report of two cases.
    Kennedy GA, Blum R, McCormack C, Prince HM.
    Australas J Dermatol; 2004 Feb 15; 45(1):34-7. PubMed ID: 14961906
    [Abstract] [Full Text] [Related]

  • 18. [Resistance to rituximab and CD20 mutation].
    Terui Y, Hatake K.
    Nihon Rinsho; 2007 Jan 28; 65 Suppl 1():416-23. PubMed ID: 17474440
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-CD20 antibody therapy for B-cell lymphomas.
    Maloney DG.
    N Engl J Med; 2012 May 24; 366(21):2008-16. PubMed ID: 22621628
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.